GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aceragen Inc (FRA:V9Z) » Definitions » Cyclically Adjusted Book per Share

Aceragen (FRA:V9Z) Cyclically Adjusted Book per Share : €47.04 (As of Mar. 2023)


View and export this data going back to . Start your Free Trial

What is Aceragen Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Aceragen's adjusted book value per share for the three months ended in Mar. 2023 was €2.523. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €47.04 for the trailing ten years ended in Mar. 2023.

During the past 12 months, Aceragen's average Cyclically Adjusted Book Growth Rate was 8.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -10.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -10.10% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 2.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Aceragen was 45.70% per year. The lowest was -15.70% per year. And the median was 10.90% per year.

As of today (2024-05-29), Aceragen's current stock price is €0.24. Aceragen's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2023 was €47.04. Aceragen's Cyclically Adjusted PB Ratio of today is 0.01.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Aceragen was 17.55. The lowest was 0.01. And the median was 1.37.


Aceragen Cyclically Adjusted Book per Share Historical Data

The historical data trend for Aceragen's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aceragen Cyclically Adjusted Book per Share Chart

Aceragen Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 73.34 63.04 46.46 42.33 45.35

Aceragen Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.19 44.41 44.92 45.35 47.04

Competitive Comparison of Aceragen's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Aceragen's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aceragen's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aceragen's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Aceragen's Cyclically Adjusted PB Ratio falls into.



Aceragen Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Aceragen's adjusted Book Value per Share data for the three months ended in Mar. 2023 was:

Adj_Book= Book Value per Share /CPI of Mar. 2023 (Change)*Current CPI (Mar. 2023)
=2.523/127.3478*127.3478
=2.523

Current CPI (Mar. 2023) = 127.3478.

Aceragen Quarterly Data

Book Value per Share CPI Adj_Book
201306 6.700 98.518 8.661
201309 42.387 98.790 54.640
201312 32.158 98.326 41.650
201403 73.179 99.695 93.477
201406 65.408 100.560 82.832
201409 58.169 100.428 73.761
201412 50.481 99.070 64.890
201503 120.760 99.621 154.370
201506 105.170 100.684 133.022
201509 94.878 100.392 120.354
201512 86.052 99.792 109.813
201603 73.174 100.470 92.749
201606 60.899 101.688 76.266
201609 49.775 101.861 62.229
201612 89.388 101.863 111.752
201703 76.902 102.862 95.208
201706 60.576 103.349 74.642
201709 47.325 104.136 57.874
201712 63.265 104.011 77.460
201803 50.471 105.290 61.045
201806 45.559 106.317 54.571
201809 40.131 106.507 47.984
201812 35.172 105.998 42.256
201903 29.905 107.251 35.509
201906 24.913 108.070 29.357
201909 20.126 108.329 23.659
201912 -5.759 108.420 -6.764
202003 -0.072 108.902 -0.084
202006 -7.788 108.767 -9.118
202009 -13.292 109.815 -15.414
202012 -33.272 109.897 -38.555
202103 12.981 111.754 14.792
202106 10.214 114.631 11.347
202109 9.038 115.734 9.945
202112 8.390 117.630 9.083
202203 7.537 121.301 7.913
202206 6.412 125.017 6.532
202209 6.042 125.227 6.144
202212 3.055 125.222 3.107
202303 2.523 127.348 2.523

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Aceragen  (FRA:V9Z) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Aceragen's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.24/47.04
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Aceragen was 17.55. The lowest was 0.01. And the median was 1.37.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Aceragen Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Aceragen's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Aceragen (FRA:V9Z) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aceragen Inc (FRA:V9Z) » Definitions » Cyclically Adjusted Book per Share
Traded in Other Exchanges
N/A
Address
505 Eagleview Boulevard, Suite 212, Exton, PA, USA, 19341
Aceragen Inc is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. The company portfolio includes late-stage programs based on well-established biological principles that are developing to be inventive therapeutics capable of addressing the unmet medical needs of individuals living with rare diseases.

Aceragen (FRA:V9Z) Headlines

No Headlines